Mayo Clinic Talks

Hosted ByMayo Clinic

Timely consultations relevant for family medicine, primary care, and general internal medicine topics for physicians, nurse practitioners, physician assistants, and residents. Offering CME credit for most episodes

Mayo Clinic Talks 161: COVID-19 Miniseries Episode 26: Mayo Clinic Q&A – Atypical Kawasaki Disease, Recombination Events, and Antiviral Therapy Updates

This episode is shared from Mayo Clinic Q&A and was recorded in May 2020.

To claim credit visit https://ce.mayo.edu/covid19podcast

Guest:  Gregory Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, discusses how SARS-CoV-2 is mutating, atypical Kawasaki disease emerging in pediatric patients, updates in antiviral therapies and how scientists and researchers are rapidly gaining new knowledge about the virus and the disease that it causes.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.